Telos Capital Management, Inc. Amgen Inc Transaction History

Telos Capital Management, Inc.

$937 Million
Q3 2024

A detailed history of Telos Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Telos Capital Management, Inc. holds 25,200 shares of AMGN stock, worth $7.42 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

25,200

Previous 25,557 1.4%

Holding current value

$7.42 Million

Previous $7.99 Million 1.68%

% of portfolio

0.87%

Previous 0.9%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $110,448 - $120,444	-357 Reduced 1.4%	25,200 $8.12 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $285,872 - $347,409	1,088 Added 4.45%	25,557 $7.99 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $8,334 - $10,061	-31 Reduced 0.13%	24,469 $6.96 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $57,532 - $64,903	-225 Reduced 0.91%	24,500 $7.06 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $383,512 - $476,140	-1,754 Reduced 6.62%	24,725 $6.65 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $43,925 - $51,940	205 Added 0.78%	26,479 $5.88 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $549,798 - $670,112	2,435 Added 10.21%	26,274 $6.35 Million
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $161,466 - $205,162	-705 Reduced 2.87%	23,839 $0
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $56,788 - $64,046	253 Added 1.04%	24,544 $5.53 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $55,601 - $61,874	-241 Reduced 0.98%	24,291 $5.91 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $98,671 - $109,156	450 Added 1.87%	24,532 $5.93 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $275,846 - $315,681	1,387 Added 6.11%	24,082 $5.42 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $23,986 - $28,103	113 Added 0.5%	22,695 $4.83 Million
Q2 2021 Jul 15, 2021	SELL	$233.58 - $259.14 $55,124 - $61,157	-236 Reduced 1.03%	22,582 $5.51 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $92,758 - $108,094	418 Added 1.87%	22,818 $5.68 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $306,610 - $365,118	1,417 Added 6.75%	22,400 $5.15 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $81,892 - $91,071	-349 Reduced 1.64%	20,983 $5.33 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $121,455 - $149,042	-614 Reduced 2.8%	21,332 $5.03 Million
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $300,513 - $398,563	1,649 Added 8.12%	21,946 $4.45 Million
Q4 2019 Jan 23, 2020	BUY	$189.21 - $243.2 $415,505 - $534,067	2,196 Added 12.13%	20,297 $4.89 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $110,211 - $132,056	633 Added 3.62%	18,101 $3.5 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $137,694 - $161,408	826 Added 4.96%	17,468 $3.22 Million
Q1 2019 Apr 18, 2019	BUY	$180.87 - $203.88 $214,692 - $242,005	1,187 Added 7.68%	16,642 $3.16 Million
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $44,778 - $52,270	251 Added 1.65%	15,455 $3.01 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $41,319 - $46,582	-223 Reduced 1.45%	15,204 $3.15 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $10,295 - $11,563	62 Added 0.4%	15,427 $2.85 Million
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $37,274 - $43,560	220 Added 1.45%	15,365 $2.62 Million
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $125,410 - $140,122	743 Added 5.16%	15,145 $2.63 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $2.41 Million - $2.75 Million	14,402	14,402 $2.69 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.

Account

Telos Capital Management, Inc. Amgen Inc Transaction History